Compound Detail
CHEMBL297884
CILUPREVIR 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)C[C@H]5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(C)C)n3)nc2c1
Basic Information
| ChEMBL ID | CHEMBL297884 |
| Name | CILUPREVIR |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | PJZPDFUUXKKDNB-KNINVFKUSA-N |
7
Targets
151
Activities
4
Assay Types
10
PK Parameters
20
Publications
4
Known Names
1
Mechanisms
Molecular Properties
774.9
MW (Da)
6.05
ALogP
11
HBA
4
HBD
181.3
PSA (Ų)
0.19
QED
3
Ro5 Violations
9
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Hepatitis C virus serine protease, NS3/NS4A inhibitor | INHIBITOR | Hepatitis C virus serine protease, NS3/NS4A | ✓ | ✓ |
Activity Summary
EC50 107 meas. best 9.4
Ki 20 meas. best 10.05
IC50 12 meas. best 9.1
Kd 12 meas. best 8.89
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| NS3 CHEMBL1293269 | Ki | 10.05 | 9.09 | 0.1 | 3 |
| Unchecked CHEMBL612545 | Ki | 10.05 | 8.916 | 0.1 | 10 |
| Hepatitis C virus serine protease, NS3/NS4A CHEMBL2095231 | Ki | 9.52 | 9.52 | 0.3 | 1 |
| Hepatitis C virus CHEMBL379 | Ki | 9.52 | 9.2933 | 0.3 | 3 |
| Hepatitis C virus CHEMBL379 | EC50 | 9.4 | 7.8925 | 0.4 | 106 |
| Hepatitis C virus serine protease, NS3/NS4A CHEMBL2095231 | IC50 | 9.1 | 9.1 | 0.8 | 1 |
| Unchecked CHEMBL612545 | IC50 | 9.05 | 7.955 | 0.9 | 8 |
| Hepatitis C virus CHEMBL379 | IC50 | 9.0 | 9.0 | 1.0 | 2 |
| Unchecked CHEMBL612545 | Kd | 8.89 | 7.66 | 1.3 | 12 |
| NS3 protease CHEMBL4296325 | Ki | 7.62 | 7.27 | 24.0 | 2 |
| NS3 protease CHEMBL4296313 | Ki | 6.7 | 6.7 | 200.0 | 1 |
| NS3 CHEMBL1293269 | IC50 | 5.52 | 5.52 | 3000.0 | 1 |
| ADMET CHEMBL612558 | EC50 | 4.3 | 4.3 | 50000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 9686.75 | ng.hr.mL-1 | Rattus norvegicus |
| Cmax | 2500.0 | nM | Rattus norvegicus |
| F | 42.0 | % | Rattus norvegicus |
| F | 7.0 | % | Macaca mulatta |
| F | 36.0 | % | Canis lupus familiaris |
| F | 13.0 | % | Rattus norvegicus |
| T1/2 | 1.3 | hr | Rattus norvegicus |
| T1/2 | 7.0 | hr | Macaca mulatta |
| T1/2 | 4.2 | hr | Canis lupus familiaris |
| T1/2 | 0.8 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 20176898 | 10.1128/aac.01452-09 | Hepatitis C virus | 89 |
| 18086851 | 10.1128/aac.01149-07 | Hepatitis C virus | 22 |
| 17908950 | 10.1128/aac.00723-07 | Hepatitis C virus | 17 |
| 24512311 | 10.1021/jm401690f | Unchecked | 12 |
| 22471376 | 10.1021/jm201278q | Hepatitis C virus | 9 |
| 19104013 | 10.1128/aac.00939-08 | Hepatitis C virus | 8 |
| 15027850 | 10.1021/jm0342414 | Rattus norvegicus | 6 |
| 19841155 | 10.1128/aac.00677-09 | Hepatitis C virus | 4 |
| 17371824 | 10.1128/aac.01004-06 | Hepatitis C virus | 4 |
| 18625766 | 10.1128/aac.01534-07 | Hepatitis C virus | 4 |
| 18625766 | 10.1128/aac.01534-07 | ADMET | 4 |
| 19896376 | 10.1016/j.bmcl.2009.10.070 | Hepatitis C virus | 3 |
| 19226162 | 10.1021/jm8010965 | Hepatitis C virus | 3 |
| 21381769 | 10.1021/jm1012374 | Hepatitis C virus | 3 |
| 23517538 | 10.1021/jm301887f | NS3 protease | 3 |
| 19841155 | 10.1128/aac.00677-09 | Unchecked | 3 |
| 21381769 | 10.1021/jm1012374 | Rhesus monkey | 2 |
| 22366653 | 10.1016/j.bmcl.2012.01.017 | Hepatitis C virus | 2 |
| 21381769 | 10.1021/jm1012374 | Canis familiaris | 2 |
| 21440437 | 10.1016/j.bmcl.2011.03.014 | Hepatitis C virus | 2 |
Data from ChEMBL 36 via Core Engine